Deva Holding A.S.'s latest marketcap:
As of 06/07/2025, Deva Holding A.S.'s market capitalization has reached $285.03 M. According to our data, Deva Holding A.S. is the 17723th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 285.03 M |
| Revenue (ttm) | 367.43 M |
| Net Income (ttm) | 15.3 M |
| Shares Out | 200.02 M |
| EPS (ttm) | 0.08 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/25/2024 |
| Earnings Date | 08/15/2025 |
Deva Holding A.S.'s yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | ₺11.4 B | -27.3% |
| 12/31/2024 | ₺15.68 B | 3.77% |
| 12/29/2023 | ₺15.11 B | 9.18% |
| 12/30/2022 | ₺13.84 B | 140.78% |
| 12/31/2021 | ₺5.75 B | 19.06% |
| 12/31/2020 | ₺4.83 B |
Company Profile
About Deva Holding A.S.
Deva Holding A.S. is a leading pharmaceutical company specializing in the manufacturing, marketing, and sales of a diverse range of pharmaceutical products. Headquartered in Istanbul, Turkey, the company has been a key player in the industry since its incorporation in 1958.
Product Portfolio
Deva Holding offers a comprehensive range of pharmaceutical solutions, including:
- Antineoplastic and immunomodulating agents
- Dermatological products
- Systemic hormonal preparations
- Anti-infective and antiparasitic products
- Food supplements and electrolyte solutions
Therapeutic Areas
The company's expertise extends to multiple therapeutic categories, such as:
- Urogenital system and sex hormones
- Blood and blood-forming organs
- Cardiovascular system
- Musculoskeletal system
- Nervous system
- Alimentary tract and metabolism
- Respiratory system
- Connective tissue and sensory organs
Product Forms and Specializations
Deva Holding manufactures products in various forms, including:
- Sterile and non-sterile formulations
- Liquids, semi-solids, and solids
- Cephalosporins and penicillin products
- Hormonal and inhalation therapies
- Oncology products (solid and liquid)
- Animal health products
- Active pharmaceutical ingredients (APIs)
- Ampoules, vials, eye drops, and medical ampoules
Global Reach
With a strong international presence, Deva Holding exports its high-quality pharmaceutical products to approximately 50 countries worldwide.
Corporate Structure
Deva Holding A.S. operates as a subsidiary of Eastpharma S.à R.L.
Frequently Asked Questions
-
What is Deva Holding A.S.'s (IST-DEVA) current market cap?As of 06/07/2025, Deva Holding A.S. (including the parent company, if applicable) has an estimated market capitalization of $285.03 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Deva Holding A.S. (IST-DEVA) rank globally by market cap?Deva Holding A.S. global market capitalization ranking is approximately 17723 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.